Flow Cytometry

流式细胞术

基本信息

项目摘要

PROJECT SUMMARY (See instructions): Core D - The Flow Cytometry Research Core provides a centralized resource of technical expertise and major instrumentation to support and enhance the experimental design and execution of basic and translational research in HIV pathogenesis and treatment that require use of flow cytometric phenotypic analysis, cell sorting, or evaluation of specific immune cell functions. A prime goal is to provide the scientific environment and the material resources to enable junior investigators to apply flow cytometry technology to their projects and to encourage established investigators to initiate innovative pilot studies. Core personnel include: the Director, Celsa Spina, PhD, D(ABMLI); a lab manager/senior technologist, with >10 yrs. experience using a broad range of cytometry instruments (T. Rambaldo); two technical specialists, each with >20 yrs. experience (M. O'Keefe, N. Sekiya); and a junior technician, with 4 yrs. experience (D. Sirypangno). Major instrumentation includes: three cell analyzers (2-laser FACS Canto I, 3-laser FACS Canto II, 2-laser iCyte LSC) and two high-speed cell sorters (3-laser FACS Aria II, 4-laser MoFlo XDP), one of which is housed within a BSL-2/3 biocontainment facility. The spectrum of HIV/AIDS research, supported by the Core, spans basic work on viral regulation and mechanisms of pathogenesis (AI038201, AI081668, AI095623, AI096113, DK035108, GM032373) to preclinical development of drugs, vaccines, and gene therapies (AI033292, AI055332, AI071803, AI076558, AI079031) to clinical studies of viral transmission (AI074621), viral latency (AI080193, AI096113), neurobiology (DA026306, MH083552, MH097520), and immune and viral responses to experimental treatments (AI064086, AI087164, MH085610). To support and promote research in each of these areas: expert consultation on experimental design and data interpretation is provided through the Core Director and technical support staff; state-of-the-art instrumentation is selected for complementary functions; equipment use is accessible through dedicated technician operators; all services are provided through an established recharge mechanism; and data analysis is customized to the specific objectives of individual research projects. The Core works with investigators to develop and apply new methods that are needed to attain the research goals of funded projects, and trains junior investigators to optimally and correctly use flow cytometry approaches to address their research hypotheses. In addition, the Core fills a special need of the San Diego HIV research community by providing a unique biocontainment facility that performs live cell sorting of HIV-infected and other biohazardous samples.
项目总结(见说明): 核心D -流式细胞术研究核心提供了技术专长和主要仪器的集中资源,以支持和加强艾滋病毒发病机制和治疗中需要使用流式细胞术表型分析,细胞分选或特定免疫细胞功能评估的基础和转化研究的实验设计和执行。一个主要目标是提供科学环境和物质资源,使初级研究人员能够将流式细胞术技术应用于他们的项目,并鼓励已建立的研究人员启动创新的试点研究。核心人员包括:主任,Celsa Spina,PhD,D(ABMLI);实验室经理/高级技术专家,拥有超过10年的经验。使用广泛的细胞仪(T. Rambaldo);两名技术专家,每人都有20年以上的经验(M。O'Keefe,N. Sekiya);和一个初级技术员,有4年的经验(D。Sirypangno)。主要仪器包括:三台细胞分析仪(2-激光FACS Canto I,3-激光FACS Canto II,2-激光iCyte LSC)和两台高速细胞分选仪(3-激光FACS Aria II,4-激光MoFlo XDP),其中一台位于BSL-2/3生物防护设施内。 核心基金支持的艾滋病毒/艾滋病研究范围涵盖病毒调节和发病机制的基础工作(AI 038201、AI 081668、AI 095623、AI 096113、DK 035108、GM 032373)用于药物、疫苗和基因疗法的临床前开发(AI 033292、AI 055332、AI 071803、AI 076558、AI 079031)用于病毒传播的临床研究(AI 074621),病毒潜伏期(AI 080193,AI 096113),神经生物学(DA 026306、MH 083552、MH 097520)以及对实验处理的免疫和病毒应答(AI 064086、AI 087164、MH 085610)。支持和促进上述每一领域的研究:通过核心主任和技术支持人员提供关于实验设计和数据解释的专家咨询;选择最先进的仪器进行补充功能;通过专门的技术操作员使用设备;通过既定的补充机制提供所有服务;数据分析是根据各个研究项目的具体目标定制的。核心与研究人员合作,开发和应用实现资助项目研究目标所需的新方法,并培训初级研究人员最佳和正确地使用流式细胞术方法来解决他们的研究假设。此外,该中心还提供了一个独特的生物隔离设施,对艾滋病毒感染和其他生物危害性样本进行活细胞分选,满足了圣地亚哥艾滋病毒研究界的特殊需求。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DOUGLAS D RICHMAN其他文献

DOUGLAS D RICHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DOUGLAS D RICHMAN', 18)}}的其他基金

Measuring the Latent Reservoir and Monitoring Eradication Strategies
测量潜在储库并监测根除策略
  • 批准号:
    8326895
  • 财政年份:
    2011
  • 资助金额:
    $ 44.94万
  • 项目类别:
Gene expression biomarkers of immune recovery in HIV infected patients
HIV感染者免疫恢复的基因表达生物标志物
  • 批准号:
    8591371
  • 财政年份:
    2009
  • 资助金额:
    $ 44.94万
  • 项目类别:
Gene expression biomarkers of immune recovery in HIV infected patients
HIV感染者免疫恢复的基因表达生物标志物
  • 批准号:
    8389836
  • 财政年份:
    2009
  • 资助金额:
    $ 44.94万
  • 项目类别:
Targeting regulators of cellular gene transcription to impact HIV latency
靶向细胞基因转录调节因子以影响 HIV 潜伏期
  • 批准号:
    7860484
  • 财政年份:
    2009
  • 资助金额:
    $ 44.94万
  • 项目类别:
Targeting regulators of cellular gene transcription to impact HIV latency
靶向细胞基因转录调节因子以影响 HIV 潜伏期
  • 批准号:
    7554818
  • 财政年份:
    2009
  • 资助金额:
    $ 44.94万
  • 项目类别:
Southern California Primary Infection Program
南加州初级感染计划
  • 批准号:
    7931675
  • 财政年份:
    2009
  • 资助金额:
    $ 44.94万
  • 项目类别:
Developmental
发育性
  • 批准号:
    7635794
  • 财政年份:
    2008
  • 资助金额:
    $ 44.94万
  • 项目类别:
Transmission Correlates
传输相关性
  • 批准号:
    8375407
  • 财政年份:
    2008
  • 资助金额:
    $ 44.94万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7694181
  • 财政年份:
    2008
  • 资助金额:
    $ 44.94万
  • 项目类别:
Administrative Core, Part 1
行政核心,第 1 部分
  • 批准号:
    7278943
  • 财政年份:
    2007
  • 资助金额:
    $ 44.94万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 44.94万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 44.94万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 44.94万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 44.94万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 44.94万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 44.94万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 44.94万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 44.94万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 44.94万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 44.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了